Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping

Conditions: DMD; Duchenne Muscular Dystrophy; Duchenne; Exon 44 Interventions: Drug: AOC 1044 Sponsors: Avidity Biosciences, Inc. Enrolling by invitation

https://clinicaltrials.gov/study/NCT06244082

Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

More News: Muscular Dystrophy | Reflex Sympathetic Dystrophy | Research | Study